Not Evidence for Baumol’s Cost Disease. A replication study of Hartwig (Journal of Health Economics, 2008)
In his 2008 Journal of Health Economics paper, Jochen Hartwig claimed that Baumol’s Cost Disease (BCD) theory could explain observed increases in health care expenditures in OECD countries. This paper replicates Hartwig’s results and demonstrates that he tested the wrong hypothesis. When one test...
Main Authors: | Akinwande Atanda, W. Robert Reed |
---|---|
Format: | Article |
Language: | English |
Published: |
ZBW
2020-03-01
|
Series: | International Journal for Re-Views in Empirical Economics |
Subjects: | |
Online Access: | https://doi.org/10.18718/81781.16 |
Similar Items
-
Not Evidence for Baumol’s Cost Disease. A Reply to Atanda and Reed (International Journal for Re-Views in Empirical Economics, 2020)
by: Jochen Hartwig
Published: (2020-06-01) -
Determinants of China’s health expenditure growth: based on Baumol’s cost disease theory
by: Linan Wang, et al.
Published: (2021-09-01) -
Real-Estate Entrepreneurship from Baumol's Productive and Unproductive Typology: A Contestable Markets Approach
by: Hande Karadag, et al.
Published: (2022-08-01) -
The Sustainability of Hospital Care in The Netherlands from a Labour Market Perspective: A Time Series Analysis of the Baumol Effect between 2000 and 2021
by: Jos Blank, et al.
Published: (2024-08-01) -
A propensity score matching analysis using statistical methods for estimating the impact of intervention: The cost of malaria and its impact on the health system
by: Mario J. Olivera, et al.
Published: (2023-12-01)